Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-04-29

Clinical Trial Update: A Randomized, Open-label Study on Helicobacter Pylori Eradication With Standard Triple Regimen Plus Acetazolamide [Phase 2]

View source ↗

Summary

A Phase 2 randomized, open-label trial evaluating addition of acetazolamide to the standard triple regimen for Helicobacter pylori infection, which has been wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACETAZOLAMIDE (acetazolamide)

Snippet

Sponsor: Yonsei University | Conditions: H. Pylori Infection | Phase 2 | Status: WITHDRAWN